Early Waning of Maternal Measles and Meningitis C Antibodies
NCT02219061 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2014-09-18
Summary
Maternal antibodies (measles and meningitis C) may wane in the first six months after birth.
* Geometric mean titers(GMTs) of measles and meningitis C.
* Follow-up on 0 month, 3rd month,5th month and 7th month after birth.
Conditions
Sponsors & Collaborators
-
Guangzhou Center for Disease Control and Prevention
lead OTHER_GOV
Principal Investigators
-
Ming Wang · Guangzhou CDC
Eligibility
- Max Age
- 7 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2014-10-31
- Completion
- 2014-12-31
Countries
- China
Study Locations
More Related Trials
-
B14 Meningococcal Carriage in Seine-Maritime Population: Prevalence Study and Search of Risk Factors
NCT00465582 ·Status: TERMINATED
-
Predictive Model for Prognosis of Chronic HBV Infection Mothers
NCT04805034 ·Status: UNKNOWN
-
Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
NCT00702663 ·Status: UNKNOWN
-
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
NCT04970836 ·Status: RECRUITING ·Phase: NA
-
Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
NCT00139113 ·Status: COMPLETED ·Phase: PHASE4
-
Mother-to-child Transmission of HBV in China
NCT05172453 ·Status: RECRUITING
-
Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
NCT02601040 ·Status: COMPLETED ·Phase: PHASE4
-
Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
NCT00142740 ·Status: COMPLETED
-
Antigen-specific Immune Response to Hepatitis B Virus in Utero
NCT00845403 ·Status: UNKNOWN
-
Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates
NCT02764671 ·Status: UNKNOWN ·Phase: PHASE4
-
Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB Infection
NCT02886182 ·Status: UNKNOWN
-
Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination
NCT01441609 ·Status: UNKNOWN
-
Prevention for Mother-to-infant Transmission of HBV
NCT02312531 ·Status: COMPLETED ·Phase: NA
-
An Observational Study of Hepatitis C Virus in Pregnancy
NCT01959321 ·Status: COMPLETED
-
The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students
NCT05099757 ·Status: UNKNOWN ·Phase: PHASE4
-
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
NCT01861613 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing
NCT03867643 ·Status: RECRUITING
-
Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing
NCT02304510 ·Status: COMPLETED
-
Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus Infection
NCT01607021 ·Status: UNKNOWN
-
Long-term Outcomes of Living Donor Liver Transplantations With Anti-HBc (+) Grafts in Pediatric Patients
NCT06290726 ·Status: COMPLETED
-
Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year
NCT04910971 ·Status: UNKNOWN
-
Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China
NCT02898922 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Characteristics, Natural Outcome and Treatment Optimization of Refractory
NCT05376124 ·Status: RECRUITING
-
Immunologic Response of Hepatitis B Vaccine
NCT03219203 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparative Immunogenicity Study of Two Hepatitis A Vaccines
NCT03231605 ·Status: UNKNOWN ·Phase: PHASE4